
Dr. Sarah Leary is a pediatric neuro-oncologist and national research leader dedicated to improving outcomes for children with brain tumors. As Executive Board Co-Chair of CBTN, she brings extensive experience in clinical trials, translational research, and international data sharing to connect scientific discovery more directly with care. Based at Seattle Children’s Hospital, Dr. Leary also chairs the Children’s Oncology Group’s Central Nervous System Committee. Her leadership helps guide CBTN’s scientific priorities and strengthen collaboration across institutions, advancing a shared vision: to learn from every child’s experience and carry those insights forward for the children who follow.